Athira Pharma (ATHA) Earnings Date, Estimates & Call Transcripts $0.63 +0.02 (+3.98%) (As of 12:37 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Athira Pharma Latest Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 1) -$0.70 Beat By $0.05 Consensus EPS (Aug. 1) -$0.75 Athira Pharma issued Q2 2024 earnings on August 1, 2024, reporting an EPS of -$0.70, which topped the consensus estimate of -$0.75 by $0.05. With a trailing EPS of -$2.97, Athira Pharma's earnings are expected to grow next year, from ($2.57) to ($1.43) per share. Earnings Press ReleaseATHA Upcoming EarningsAthira Pharma's next earnings date is estimated for Thursday, November 14, 2024, based off prior year's reporting schedules. Get Athira Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Athira Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataATHA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATHA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it. So go here now to read my new report The Big AI Die-Up… while you still can. Athira Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.57) EPSNext Year EPS Consensus Estimate: ($1.43) EPS Athira Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/1/2024--$0.75-$0.70+$0.05-$0.70-- 5/15/2024--$0.80-$0.69+$0.11-$0.69-- 2/22/2024Q4 2023-$0.96-$0.71+$0.25-$0.71-- 11/9/2023Q3 2023-$0.87-$0.87--$0.87-- 8/10/2023Q2 2023-$0.81-$0.78+$0.03-$0.78-- 5/11/2023Q1 2023-$0.66-$0.73 -$0.07-$0.73-- Get the Latest News and Ratings for ATHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. 3/23/2023Q4 2022-$0.70-$0.79 -$0.09-$0.79-- 11/10/2022Q3 2022-$0.67-$0.53+$0.14-$0.53-- Athira Pharma Earnings - Frequently Asked Questions When is Athira Pharma's earnings date? Athira Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on ATHA's earnings history. Did Athira Pharma beat their earnings estimates last quarter? In the previous quarter, Athira Pharma (NASDAQ:ATHA) reported ($0.70) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.75) by $0.05. Learn more on analysts' earnings estimate vs. ATHA's actual earnings. How much profit does Athira Pharma generate each year? Athira Pharma (NASDAQ:ATHA) has a recorded net income of -$117.67 million. ATHA has generated -$2.97 earnings per share over the last four quarters. What is Athira Pharma's EPS forecast for next year? Athira Pharma's earnings are expected to grow from ($2.57) per share to ($1.43) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Aligos Therapeutics Earnings Passage Bio Earnings Cellectar Biosciences Earnings ALX Oncology Earnings Verrica Pharmaceuticals Earnings Spero Therapeutics Earnings Citius Pharmaceuticals Earnings RAPT Therapeutics Earnings ZIVO Bioscience Earnings Omega Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer Spending The pin that pops the AI bubble (Ad)My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it. So go here now to read my new report The Big AI Die-Up… while you still can. This page (NASDAQ:ATHA) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athira Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athira Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
